Annual CFO
-$81.17 M
-$51.95 M-177.79%
December 31, 2023
Summary
- As of February 12, 2025, MLYS annual cash flow from operations is -$81.17 million, with the most recent change of -$51.95 million (-177.79%) on December 31, 2023.
- During the last 3 years, MLYS annual CFO has fallen by -$78.71 million (-3195.70%).
- MLYS annual CFO is now -3195.70% below its all-time high of -$2.46 million, reached on December 1, 2020.
Performance
MLYS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$50.19 M
-$20.04 M-66.48%
September 30, 2024
Summary
- As of February 12, 2025, MLYS quarterly cash flow from operations is -$50.19 million, with the most recent change of -$20.04 million (-66.48%) on September 30, 2024.
- Over the past year, MLYS quarterly CFO has dropped by -$21.20 million (-73.17%).
- MLYS quarterly CFO is now -817.64% below its all-time high of -$5.47 million, reached on June 1, 2022.
Performance
MLYS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$128.45 M
-$31.16 M-32.02%
September 30, 2024
Summary
- As of February 12, 2025, MLYS TTM cash flow from operations is -$128.45 million, with the most recent change of -$31.16 million (-32.02%) on September 30, 2024.
- Over the past year, MLYS TTM CFO has dropped by -$47.28 million (-58.24%).
- MLYS TTM CFO is now -1852.75% below its all-time high of -$6.58 million, reached on March 1, 2022.
Performance
MLYS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MLYS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -177.8% | -73.2% | -58.2% |
| 3 y3 years | -3195.7% | -146.2% | -155.2% |
| 5 y5 years | -3195.7% | -146.2% | -155.2% |
MLYS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -457.6% | at low | -817.6% | at low | -1852.8% | at low |
| 5 y | 5-year | -3195.7% | at low | -817.6% | at low | -1852.8% | at low |
| alltime | all time | -3195.7% | at low | -817.6% | at low | -1852.8% | at low |
Mineralys Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$50.19 M(+66.5%) | -$128.45 M(+32.0%) |
| Jun 2024 | - | -$30.15 M(+57.5%) | -$97.30 M(+11.1%) |
| Mar 2024 | - | -$19.14 M(-34.0%) | -$87.54 M(+7.8%) |
| Dec 2023 | -$81.17 M | -$28.98 M(+52.3%) | -$81.17 M(+30.1%) |
| Sep 2023 | - | -$19.03 M(-6.6%) | -$62.38 M(+23.9%) |
| Jun 2023 | - | -$20.39 M(+59.6%) | -$50.34 M(+42.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$12.78 M(+25.4%) | -$35.42 M(+21.2%) |
| Dec 2022 | -$29.22 M(+100.7%) | -$10.19 M(+45.8%) | -$29.22 M(+53.5%) |
| Sep 2022 | - | -$6.99 M(+27.8%) | -$19.04 M(+58.0%) |
| Jun 2022 | - | -$5.47 M(-16.9%) | -$12.05 M(+83.1%) |
| Mar 2022 | - | -$6.58 M | -$6.58 M |
| Dec 2021 | -$14.56 M(+491.1%) | - | - |
| Dec 2020 | -$2.46 M | - | - |
FAQ
- What is Mineralys Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual CFO year-on-year change?
- What is Mineralys Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly CFO year-on-year change?
- What is Mineralys Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM CFO year-on-year change?
What is Mineralys Therapeutics annual cash flow from operations?
The current annual CFO of MLYS is -$81.17 M
What is the all time high annual CFO for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual cash flow from operations is -$2.46 M
What is Mineralys Therapeutics annual CFO year-on-year change?
Over the past year, MLYS annual cash flow from operations has changed by -$51.95 M (-177.79%)
What is Mineralys Therapeutics quarterly cash flow from operations?
The current quarterly CFO of MLYS is -$50.19 M
What is the all time high quarterly CFO for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly cash flow from operations is -$5.47 M
What is Mineralys Therapeutics quarterly CFO year-on-year change?
Over the past year, MLYS quarterly cash flow from operations has changed by -$21.20 M (-73.17%)
What is Mineralys Therapeutics TTM cash flow from operations?
The current TTM CFO of MLYS is -$128.45 M
What is the all time high TTM CFO for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM cash flow from operations is -$6.58 M
What is Mineralys Therapeutics TTM CFO year-on-year change?
Over the past year, MLYS TTM cash flow from operations has changed by -$47.28 M (-58.24%)